PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Mar-2021 Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Ormat Technologies, Inc. (ORA) on Behalf of Investors Businesswire
04-Mar-2021 NANOBIOTIX and PharmaEngine Mutually Agree to Conclude Collaboration Businesswire
04-Mar-2021 Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic Sclerosis-Associated Interstitial Lung Disease, a Rare, Debilitating Condition Businesswire
04-Mar-2021 Compass Therapeutics Announces Participation in March 2021 Investor Conferences Businesswire
04-Mar-2021 Award-Winning GrandView® AI Analytics Platform Features at Automate Forward 2021 and IMPACT Smart Manufacturing Summit Businesswire
04-Mar-2021 Compass Therapeutics to Commence Trading on the OTCQB Venture Market Under the Symbol “CMPX” Businesswire
04-Mar-2021 Puma Biotechnology to Present at the Barclays Global Healthcare Conference Businesswire
04-Mar-2021 Certara Reports Preliminary Fourth Quarter and Full Year 2020 Results and Issues Full Year 2021 Guidance Businesswire
04-Mar-2021 Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results Businesswire
04-Mar-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Athenex, Inc. (ATNX) on Behalf of Investors Businesswire
04-Mar-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of XL Fleet Corp. (XL) on Behalf of Investors Businesswire
04-Mar-2021 SHAREHOLDER ALERT: Robbins LLP Announces That Aquestive Therapeutics, Inc. (AQST) is Being Sued for Misleading Shareholders Businesswire
04-Mar-2021 MJH Life Sciences™ COVID-19 Coalition Partners With the International Society for Vaccines on Live Webinar Designed to Combat “Vaccine Hesitancy” Businesswire
04-Mar-2021 Genomic Vision Announces the Issuance of the 2nd Tranche of Convertible Notes With Warrants (OCABSA) for €1.2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €12 Million Businesswire
04-Mar-2021 New legislation to support medicine substitutions TGA
04-Mar-2021 Akelos Inc.'s Lead Compound Achieves Preclinical Safety Milestone Newswire
04-Mar-2021 Takeda sichert sich die weltweiten Rechte von Ovid Therapeutics zur Entwicklung und Vermarktung von Soticlestat für die Behandlung von Kindern und Erwachsenen mit Dravet-Syndrom und Lennox-Gastaut-Syndrom Businesswire
04-Mar-2021 The Law Offices of Frank R. Cruz Announces Investigation of Aquestive Therapeutics, Inc. (AQST) on Behalf of Investors Businesswire
04-Mar-2021 Pharmaceutical Strategies Group Unveils Solution to Double Drug Cost Savings Businesswire
04-Mar-2021 Just under 2 weeks until SMi’s 2nd Annual AI in Drug Delivery 2021, sponsored by CAS, Dassault Systèmes and Gero SMi Group